Table 2.
Description of symptoms in the long COVID group.
| Symptom | Data* |
|---|---|
| Respiratory symptoms | |
| Dyspnoea | 4/30 (13.3%) |
| Cough | 4/30 (13.3%) |
| Cardiovascular symptoms | |
| Orthostatic dysfunction | 2/30 (6.6%) |
| Dizziness | 2/30 (6.6%) |
| Positional vertigo | 1/30 (3.3%) |
| Generalised symptoms | |
| Fatigue | 20/30 (66.6%) |
| PIMS | 3/30 (10%) |
| Fever | 1/30 (3.3%) |
| Neurological symptoms | |
| Headache | 3/30 (10%) |
| Gastrointestinal symptoms | |
| Abdominal pain | 3/30 (10%) |
| Diarrhoea | 2/30 (6.6%) |
| Nausea | 1/30 (3.3%) |
| Gastroenteritis | 1/30 (3.3%) |
| Vomiting | 1/30 (3.3%) |
| Musculoskeletal symptoms | |
| Myalgia | 2/30 (6.6%) |
| Joint pain | 2/30 (6.6%) |
| Ear, nose, and throat symptoms | |
| Loss of taste and/or smell | 3/30 (10%) |
| Parosmia | 2/30 (6.6%) |
| Psychological/psychiatric symptoms | |
| Concentration difficulties | 7/30 (23.3%) |
| Sleep difficulties | 2/30 (6.6%) |
| Anxiety | 2/30 (6.6%) |
PIMS, paediatric inflammatory multisystem syndrome; MISC, multisystem inflammatory syndrome in children.
*
Data are presented as n/N (%).